重组人脑利钠肽治疗急性心肌梗死合并心衰疗效观察

Effect of recombinant human brain natriuretic peptide in the treatment of acute myocardial infarction complicated with heart failure

目的:探讨重组人脑利钠肽治疗急性心肌梗死合并心衰的疗效。方法:收治急性心肌梗死合并心衰患者100例,随机分为观察组和对照组。观察组采用重组人脑利钠肽治疗,对照组采用常规治疗。结果:观察组总有效率高于对照组(P<0.05),观察组血清超敏C反应蛋白、左室射血分数、DBP、SBP、HR与对照组比较,差异有统计学意义(P<0.05)。结论:重组人脑利钠肽治疗急性心肌梗死合并心衰疗效显著。

Objective：To explore the effect of recombinant human brain natriuretic peptide in the treatment of acute myocardial infarction complicated with heart failure.Methods：100 patients with acute myocardial infarction complicated with heart failure were selected.They were randomly divided into the observation group and the control group.The observation group was treated with recombinant human brain natriuretic peptide,and the control group was treated with routine treatment.Resuhs：The total effective rate in the observation group was higher than that in the control group（P〈 0.05）.There was a significant difference in serum high-sensitivity C reactive protein,left ventricular ejection fraction,DBP,SBP and HR between groups（P 〈 0.05）.Conclusion： The effect of recombinant human brain natriuretic peptide in the treatment of acute myocardial infarction complicated with heart failure was significant.